/PRNewswire/ Saks.com LLC ("Saks"), the premier luxury ecommerce platform, has closed on a syndicated $350 million asset-based five-year revolving credit.
Three Months Ended March 31, 2021 Results
Net Loss was $69.7 million compared to a Net Loss of $22.6 million in 2020. Net Loss for the three months ended March 31, 2021 includes $24.0 million of property and equipment impairment losses.
Adjusted Net Loss
Owned Resort EBITDA decreased 89.2% versus 2020 to $6.5 million.
Adjusted EBITDA decreased 105.0% versus 2020 to $(2.5) million.
(1)
Adjusted Net Income/(Loss) excludes special items, which are those items deemed not to be reflective of ongoing operations. See Definitions of Non-U.S. GAAP Measures and Operating Statistics for a description of how we compute Adjusted Net Income/(Loss) and other non-GAAP financial figures included in this press release. The first quarter finished on a strong note despite the change in international travel guidelines issued in January by the CDC. March was a very important milestone for Playa s recovery journey: it was the first month since the onset of the
Cansortium Completes $71 Million Debt Financing
News provided by
Share this article
Additional Liquidity Significantly Strengthens Balance Sheet
Proceeds to Fund Expansion in Florida, Pennsylvania and Michigan
MIAMI, April 30, 2021 /PRNewswire/ - Cansortium Inc. ( Cansortium or the Company ) (CSE: TIUM.U), (OTCQB: CNTMF), a vertically-integrated cannabis company operating under the Fluent™ brand, today announced it has closed a US$71 million Senior Secured Term Loan due April 29, 2025 (the Term Loan ) with a syndicate led by U.S.-based institutional lenders.
The Term Loan will bear interest of 13% annually, with a four-year maturity and 18 months of call protection. The Term Loan consists of a $50 million tranche priced with an original issue discount of 3% that includes warrants to acquire 12.5 million common shares of common stock at an exercise price of $1.20 per share, as well as a $21 million tranche priced with an original issue discount of 7% with no equity compone
LivaNova PLC: LivaNova Reports First Quarter 2021 Results
LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2021.
For the first quarter of 2021, worldwide sales from continuing operations were $247.6 million, an increase of 2.1 percent on a reported basis and a decline of 0.4 percent on a constant-currency
1 basis, as compared to the same quarter of the previous year. On the basis of U.S. Generally Accepted Accounting Principles (GAAP), first quarter 2021 diluted loss per share from continuing operations was $0.61. First quarter 2021 adjusted diluted earnings per share from continuing operations was $0.35. Epilepsy sales growth in the quarter reflects improving market dynamics, especially in the United States. The pace of vaccination efforts, along with patients and their caregivers willingness to seek treatment, is key to the continued recovery of the Epilepsy business, said Damie
Alaska Airlines Group issued this financial report: Financial Results: Reported a net loss for the first quarter of 2021 under Generally Accepted Accounting Principles (GAAP) of $131 million, or $1.05 per share, compared to a net loss of $232 million, or $1.89 per share in the first quarter of 2020. Reported a net loss for the first quarter of 2021, excluding…